← Eichor
Condition: Oral Bacterial Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Oral Bacterial Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administ
Phase 1/Phase 2 · 8 location(s) · SNIPR Biome Aps. · NCT06938867Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care
Phase 4 · 13 location(s) · Uppsala University · NCT07236944Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome
NA · 2 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT05444946Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
Phase N/A · 1 location(s) · Scynexis, Inc. · NCT05908682Oropharyngeal Candidiasis (OPC) and S-ECC
Phase N/A · 1 location(s) · Temple University · NCT05761197STI Testing to Enhance PrEP Use in Pregnancy
Phase 3 · 1 location(s) · Botswana Harvard AIDS Institute Partnership · NCT06919614Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07683104FMT Capsules for rCDI
Phase 3 · 1 location(s) · Helsinki University Central Hospital · NCT07458984Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children
NA · 1 location(s) · Alexandria University · NCT07184203Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Diseas
Phase 2 · 1 location(s) · Eveliqure Biotechnologies GmbH · NCT07049159Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents
Phase 1 · 1 location(s) · Iterum Therapeutics, International Limited · NCT07092813Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tube
Phase 3 · 5 location(s) · Huashan Hospital · NCT05081401Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs
Phase 3 · 5 location(s) · Lund University · NCT05224401Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya
Phase 4 · 1 location(s) · Albert B. Sabin Vaccine Institute · NCT07487077A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers
Phase 1 · 1 location(s) · Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · NCT06082323Rheumatology Patient Registry and Biorepository
Phase N/A · 1 location(s) · Yale University · NCT04402086TREAT-SC: Early, Short Course Oral Dexamethasone for the Treatment of Sydenham Chorea in Children
Phase 3 · 17 location(s) · Starship Child Health, Te Toka Tumai Auckland · NCT06259006A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients
Phase 3 · 2 location(s) · Shanghai Jiatan Pharmatech Co., Ltd · NCT05824871Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome
Phase 1 · 1 location(s) · Central Hospital, Nancy, France · NCT05302531Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole
Phase 4 · 4 location(s) · Tulane University · NCT06261840Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract
NA · 1 location(s) · University of California, Irvine · NCT05603650Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor
Phase 4 · 1 location(s) · Khyber Teaching Hospital · NCT06922344Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)
Phase 2 · 26 location(s) · Merck Sharp & Dohme LLC · NCT04665037A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invas
Phase 3 · 144 location(s) · Basilea Pharmaceutica · NCT05421858Partial Oral Antibiotic Treatment for Bacterial Brain Abscess
Phase 4 · 4 location(s) · Henrik Nielsen · NCT04140903A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participant
Phase 3 · 285 location(s) · AbbVie · NCT05889182Characterizing the Inflammation Around Dental Implants: Bacterial Infection, Hypersensitivity or Both?
Phase N/A · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06515886Effect of Lactobacillus Johnsonii or White Pomegranate Extract on the Vaginal Health
NA · 1 location(s) · Chung Shan Medical University · NCT06069531
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.